metabolism and response to anti-cgrp treatments in migraine
Published 3 months ago • 30 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:55
treating migraines in patients not responding to cgrp monoclonal antibodies
-
1:47
anti-cgrp monoclonal antibodies for difficult to treat migraines: deliver trial
-
4:05
for or against? anti-cgrp monoclonal antibodies as a first-line therapy for migraines
-
1:40
cgrp mabs have changed migraine treatment approaches
-
2:04
targeting cgrp for migraine prevention: the story so far
-
4:58
combination treatment with cgrp mabs and onabotulinumtoxina for chronic migraine control
-
8:29
real-world data on anti-cgrp monoclonal antibodies
-
14:28
advantages of oral anti-cgrp drugs in migraine prevention
-
5:16
cgrp in the treatment & prevention of migraine - american academy of neurology
-
18:18
migraine prevention in the real world: exploring the role of anti-cgrp antibodies
-
2:52
is the cgrp ligand or receptor a better target in migraine?
-
22:19
adverse events of anti-cgrp monoclonal antibodies for migraine - migraine masterclass: webinar 6
-
1:30
migraine: cgrp mabs efficacy measured over time
-
7:33
response to cgrp inhibitors: refractory migraine & drug overuse
-
18:22
migraine prevention in the real world: exploring the role of anti-cgrp antibodies
-
2:09
blocking cgrp in migraine patients: cardiovascular implications
-
32:41
november headache series: update on migraine treatments and cgrp inhibitors
-
17:37
new data shows delay in anti-cgrp medication response for some
-
46:12
migraine treatment update - mathew robbins, md